S1 Ep38: Getting Educated On Advances Made With GI Cancers in Houston
Recently, we traveled to Houston, Texas, for a State of the Science Summit™ on Gastrointestinal Malignancies. At the meeting, faculty from the University of Texas MD Anderson Cancer Center and Baylor College of Medicine, discussed the rapidly evolving landscapes of colorectal cancer, gastric/GEJ cancer, pancreatic cancer, neuroendocrine tumors, and hepatocellular carcinoma.
23m Apr 18, 2019
23m
S1 Ep37: Highlighting Breakthroughs in Breast Cancer in Nashville
We recently ventured to Nashville, Tennessee for a State of the Science SummitTM on Breast Cancer. At this conference, we sat down with faculty from Sarah Cannon Research Institute, HCA Midwest Health, Virginia Cancer Specialists, and Memorial Sloan Kettering Cancer Center to discuss some of the practice-changing updates that have been occurring in the field.
21m Apr 10, 2019
21m
S1 Ep36: Spotlight on Clinical Scenarios in GEJ Cancer
We recently traveled to Pasadena, California for a State of the Science Summit™ on Gastrointestinal Malignancies. In keeping up with the rapidly changing landscape of gastroesophageal junction cancer, we sat down with Joseph Chao, MD, to discuss a clinical scenario he faced in practice, and how he used the latest data available to inform his treatment for his patient.
28m Apr 03, 2019
28m
S1 Ep35: Gaining Insight Into Progress Made With Genitourinary Cancers in Pasadena
We recently traveled to Pasadena, California, for a State of the Science Summit™ on Genitourinary Malignancies. At the meeting, faculty from City of Hope, Huntsman Cancer Center, and the University of Washington discussed the rapidly evolving landscapes of kidney, bladder, and prostate cancer.
25m Mar 27, 2019
25m
S1 Ep34: Navigating New Advances in Breast Cancer in NYC
We recently traveled to New York City for a State of the Science Summit™ on Breast Cancer. During the meeting, faculty from the Icahn School of Medicine of Mount Sinai Health System, as well as Columbia University Medical Center, discussed the latest updates in the rapidly evolving paradigms of triple-negative breast cancer, HER2-positive breast cancer, hormone receptor-positive, HER2-negative ...
20m Mar 20, 2019
20m
S1 Ep33: Spotlight on Clinical Scenarios in Rectal Adenocarcinoma
We sat down with Marwan Fakih, MD, to discuss a clinical scenario he faced in practice, and how he used the latest data available to inform his treatment for his patient.
20m Mar 15, 2019
20m
S1 Ep32: Observing the Latest Advances in Ovarian Cancer in Boston
We recently traveled to Boston, Massachusetts, for a State of the Science Summit™ on Ovarian Cancer and Soft Tissue Sarcoma. During the meeting, faculty from Dana-Farber Cancer Institute gave focused presentations on the facets of genetic testing in ovarian cancer, surgical options available for patients with newly diagnosed disease, and emerging strategies for the treatment of patients with ut...
22m Mar 06, 2019
22m
S1 Ep31: Learning More About Lung Cancer in Kansas City
We recently traveled to Kansas City, Missouri, for a State of the Science Summit™ on Advanced Non–Small Cell Lung Cancer. During the meeting, the faculty from St. Luke’s Cancer Institute and the University of Missouri-Kansas City gave focused presentations on recent progress made in squamous NSCLC and small cell lung cancer, provided tips on how to navigate the complex paradigm of oncogene-driv...
17m Feb 28, 2019
17m
S1 Ep30: Getting Up to Speed with Progress Made in GU Cancers in Memphis
We recently traveled to Memphis, Tennessee, for a State of the Science Summit™ on Genitourinary Cancers. During the meeting, the faculty gave focused presentations on advances made in the treatment landscapes of metastatic renal cell carcinoma and prostate cancer. In renal cell carcinoma, the faculty homed in on the role of adjuvant TKIs, the current and future use of immunotherapy, the utilit...
20m Feb 20, 2019
20m
S1 Ep29: Highlighting Headway Made in NSCLC in New York
We recently traveled to New York City for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. The meeting, which featured insight from experts from NYU Langone’s Perlmutter Cancer Center, covered a wide array of topics, ranging from surgical techniques, to headway made in immunotherapy, to emerging biomarkers, to diagnostic advancements.
16m Feb 13, 2019
16m
S1 Ep28: Examining Breakthroughs Made in Breast Cancer in Minneapolis
We recently traveled to Minneapolis, Minnesota, for a State of the Science Summit on Breast Cancer. At the meeting, topics ranged from surgical approaches for node-positive breast cancer, to the use of CDK4/6 inhibitors in hormone receptor–positive disease, to emerging drug therapies in triple-negative disease. Presenters also highlighted treatment approaches for those with lymphedema, discusse...
18m Feb 06, 2019
18m
S1 Ep27: Navigating New Advances Made in NSCLC in New York
We recently traveled to Syracuse, New York, for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. At the meeting, we spoke with the faculty of Upstate Medical University on practice-change clinical trials in the space, as well as novel approaches to treatment with checkpoint inhibitors, targeted therapies, radiation, and minimally invasive surgery. They also discussed the im...
26m Jan 30, 2019
26m
S1 Ep26: Making Moves in Multiple Myeloma in NYC
We recently traveled to New York City for a State of the Science Summit on Multiple Myeloma. At the meeting, we spoke with the faculty of Mount Sinai to get their take on stem cell transplant, minimal residual disease, maintenance options, and treatment approaches for newly diagnosed myeloma. They also discussed outcomes for relapsed/refractory disease, novel agents in development, chimeric ant...
26m Jan 23, 2019
26m
S1 Ep25: Perusing Progress Made in NSCLC in Washington DC
Recently, we headed to Washington D.C. for a State of the Science Summit on Non–Small Cell Lung Cancer. Topics ranged from determining optimal strategies for molecular interrogation in NSCLC to the emergence of rare, targetable biomarkers—such as MET, RET, and NTRK. Presentations also focused on additional recent advances in the NSCLC and small cell lung cancer paradigms, touching on TKIs, immu...
21m Jan 16, 2019
21m
S1 Ep24: Talking Treatment Strategies for Breast Cancer in Pittsburgh
Recently, we visited Pittsburgh, Pennsylvania for a State of the Science Summit on Breast Cancer. Topics of discussion ranged from controversies in the management of hormone receptor-positive breast cancer to de-escalating therapy for patients with HER2-positive disease. Presentations also focused on novel approaches in metastatic triple-negative breast cancer and treatment strategies for patie...
22m Jan 09, 2019
22m
S1 Ep23: Snapshot of the 2018 ASH Annual Meeting in San Diego
In December 2018, we traveled to San Diego, California for the 2018 ASH Annual Meeting. At the conference, we spoke with several experts across hematologic malignancies, including mantle cell lymphoma, chronic lymphocytic leukemia, and multiple myeloma.
18m Jan 04, 2019
18m
S1 Ep22: Buzzing With News From the San Antonio Breast Cancer Symposium
We visited San Antonio, Texas for the San Antonio Breast Cancer Symposium. At the meeting, physicians from all around the world presented studies in the field, several of which will have an immediate impact on practice. During our time there, we spoke to several principal investigators who detailed new applications of novel therapies, surgical intervention strategies, and lifestyle modifications.
22m Dec 22, 2018
22m
S1 Ep21: Exploring Strides Made in Ovarian Cancer & STS in Stanford
We visited Stanford, California for a State of the Science Summit on Ovarian Cancer and Soft Tissue Sarcoma. The meeting covered advances made in the treatment landscapes, touching on available modalities, such as immunotherapy, antibody drug conjugates, and PARP inhibitors.
20m Dec 19, 2018
20m
S1 Ep20: Reflecting on New Advances Made in NSCLC in Chicago
On October 23, we traveled to Chicago, Illinois, for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. At the meeting, faculty from Rush University Medical Center, the University of Chicago Medicine, the University of Illinois at Chicago, NorthShore University Health System, and Northwestern Feinberg School of Medicine reflected on updates in the field, particularly data fro...
21m Dec 05, 2018
21m
S1 Ep19: Gaining Insight Into Genitourinary Cancers in Charlotte
We visited Charlotte, North Carolina for a State of the Science Summit on Genitourinary Cancers. The meeting covered practice-changing clinical trials in nonmetastatic castration-resistant prostate cancer, treatment options for those with castration-sensitive prostate cancer, and the role of surgery in high-risk prostate cancer. Additionally, immunotherapy in advanced renal cell carcinoma was d...
24m Nov 28, 2018
24m
S1 Ep18: Keeping Up With Hematologic Advances in Clayton
We visited Clayton, Missouri for a State of the Science Summit on Hematologic Malignancies with faculty from Washington University School of Medicine in St. Louis and Siteman Cancer Center. The meeting covered novel agents and combinations in chronic lymphocytic leukemia, advances in acute myeloid leukemia, management of newly diagnosed and relapsed/refractory multiple myeloma, progress in myel...
26m Nov 21, 2018
26m
S1 Ep17: Getting Educated With GI Cancer Therapies in Newport Beach
We flew to Newport Beach, California, for a State of the Science Summit on Gastrointestinal Cancers. The meeting focused on the evolving paradigms of colorectal cancer, pancreatic cancer, neuroendocrine tumors, gastric cancer, and hepatocellular carcinoma.
24m Nov 14, 2018
24m
S1 Ep16: Acquiring Lung Cancer Lessons in New Jersey
We visited Summit, New Jersey for a State of the Science Summit on non–small cell lung cancer. The meeting covered the current standard of care for early-stage lung cancer, approaches to locoregionally advanced NSCLC, updates in EGFR-positive NSCLC, emerging biomarkers, new data surrounding immunotherapy combinations, updates in squamous NSCLC, and advances in small cell lung cancer.
21m Nov 09, 2018
21m
S1 Ep15: On the Floor at the 2018 ESMO Congress
The 2018 ESMO Congress brought us all the way to Munich, Germany. At this annual congress, data across various tumor types were presented, including genitourinary malignancies, breast cancer, head and neck squamous cell carcinoma, melanoma, gastrointestinal malignancies, and lung cancer.
24m Oct 31, 2018
24m
S1 Ep14: Clued in to Hematologic Cancer Treatment in Cleveland
We traveled to Cleveland, Ohio for a State of the Science Summit on Hematologic Malignancies. The meeting covered the evolving paradigm of chronic lymphocytic leukemia, updates in mantle cell lymphoma, treatment options for patients with newly diagnosed and relapsed/refractory multiple myeloma, unmet needs in myeloproliferative neoplasms, interesting genomic research in acute myeloid leukemia, ...
23m Oct 25, 2018
23m
S1 Ep13: Spreading Awareness of Breast Cancer Advancements With UCSF Faculty
We returned to San Francisco, California for a State of the Science Summit on Breast Cancer. The meeting covered the use of CDK4/6 inhibitors in metastatic hormone receptor-positive breast cancer, adjuvant and neoadjuvant HER2-targeted therapy in early-stage HER2-positive disease, immunotherapy in triple-negative disease, and more.
24m Oct 18, 2018
24m
S1 Ep12: Sharing Insight on Myeloma, CAR T, and More in San Francisco
On September 29th, we traveled to San Francisco, California for a State of the Science Summit on Hematologic Malignancies. The meeting covered novel agents and combinations in lymphoma, updates in acute and chronic leukemias, and modalities in the management of multiple myeloma.
21m Oct 10, 2018
21m
S1 Ep11: Tackling Genitourinary Cancer Topics in Chicago
We visited Chicago, Illinois for a State of the Science Summit on Renal Cell Carcinoma and Bladder Cancer. The meeting covered the genomics of bladder cancer, novel approaches to non-muscle invasive bladder cancer, side effect management from immunotherapy, as well as the integration of immunotherapy, chemotherapy, and targeted therapy in both urothelial carcinoma and kidney cancer.
21m Oct 03, 2018
21m
S1 Ep10: Third Time's a Charm: Sailing to Seattle for More Hematologic Cancer Updates
We headed to Seattle, Washington for a State of the Science Summit on Hematologic Malignancies with faculty of Seattle Cancer Care Alliance and Fred Hutchinson Cancer Research Center. The meeting covered the latest updates in Hodgkin lymphoma, mantle cell lymphoma, multiple myeloma, myeloproliferative neoplasms, acute myeloid leukemia, chronic myeloid leukemia, chronic lymphocytic leukemia, and...
27m Sep 26, 2018
27m
S1 Ep9: Diving Into Hematologic Diseases in Dearborn
We visited Dearborn, Michigan for a State of the Science Summit on Hematologic Malignancies with faculty of Karmanos Cancer Institute. The meeting covered updates and emerging treatment approaches in newly diagnosed and relapsed/refractory multiple myeloma, Hodgkin lymphoma, T-cell lymphoma, acute myeloid leukemia, chronic myeloid leukemia, myelodysplastic syndrome, CAR T-cell therapy, and chro...
23m Sep 19, 2018
23m
S1 Ep8: Taking Lessons From Hematology Experts in Tampa
We headed to Tampa, Florida for a State of the Science Summit on Hematologic Malignancies. The meeting covered updates in follicular lymphoma, chronic lymphocytic leukemia, mantle cell lymphoma, multiple myeloma, acute lymphoblastic leukemia, chronic myeloid leukemia, acute myeloid leukemia, myeloproliferative neoplasms, and CAR T-cell therapy.
25m Sep 12, 2018
25m
S1 Ep7: Learning the Lung Cancer Landscape in Hanover
We traveled to Hanover, Maryland for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. The meeting covered the use of immunotherapy in metastatic and early-stage disease, management of immune-related toxicities, predictive biomarkers, and emerging therapies in small cell lung cancer.
32m Sep 05, 2018
32m
S1 Ep6: Obtaining the Latest in Ovarian Cancer in Charlotte
On August 16th, we traveled to Charlotte, North Carolina for a State of the Science Summit on Ovarian Cancer. The meeting covered genetic testing, frontline therapies, surgical options, treatment for recurrent disease, immunotherapy, and updates in uterine sarcomas.
21m Aug 29, 2018
21m
S1 Ep5: Expanding on Emerging Agents in GI Cancers in Dallas
We traveled to Dallas, Texas for a State of the Science Summit on Gastrointestinal Malignancies. The meeting covered emerging therapies in pancreatic cancer, updates in neuroendocrine tumors, the management of metastatic colorectal cancer, recent data in hepatocellular carcinoma, and the clinical application of precision medicine in GI cancers.
21m Aug 22, 2018
21m
S1 Ep4: Navigating Non–Small Cell Lung Cancer Treatment in Charlottesville
On August 7, we traveled to Charlottesville, Virginia for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. The conference spanned early-stage advances, established and emerging treatments for oncogenic-driven disease, chemotherapy, immunotherapy, and the role of radiation.
25m Aug 15, 2018
25m
S1 Ep3: Advanced Non–Small Cell Lung Cancer Meeting in Denver
We went out to Denver, Colorado for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. The conference spanned screening, molecular profiling, early-stage advances, treatment for oncogenic-driven advanced disease, and immunotherapy.
24m Aug 08, 2018
24m
S1 Ep2: Breast Cancer Meeting in Houston
We traveled to Houston, Texas for a State of the Science Summit on Breast Cancer on July 11, 2018. The conference covered radiation therapy, triple-negative breast cancer, BRCA-positive tumors, takeaways from the 2018 ASCO Annual Meeting, and more.
30m Jul 24, 2018
30m
S1 Ep1: 2018 ASCO Annual Meeting Recap in Kansas City
We headed out to Kansas City, Missouri for a State of the Science Summit on June 30, 2018, which spanned several tumor types and covered the highlights from the 2018 ASCO Annual Meeting. We’ll hear those takeaways from each of the faculty who presented at the summit, starting with our chair, Suman Kambhampati, MD, who is co-medical director of the Blood Cancer Program of Sarah Cannon Research I...
27m Jul 10, 2018
27m